ID

38822

Beschreibung

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones; ODM derived from: https://clinicaltrials.gov/show/NCT02180334

Link

https://clinicaltrials.gov/show/NCT02180334

Stichworte

Versionen (1)
  1. 06.11.19 06.11.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

6. November 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT02180334

Englisch

Eligibility Diabetes Mellitus, Type 2 NCT02180334

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
bmi < 35 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
hba1c 6.5~8.0% for whom is on lifestyle modification only, 6.0~8.0% for whom is taking oral antidiabetic drug(s).
Beschreibung

Hemoglobin A1c measurement | Life Style Modification | Antidiabetics Oral

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
UMLS CUI [2,1]
C0023676
UMLS CUI [2,2]
C3840684
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
on lifestyle modification or oral antidiabetic therapy (sulfonylurea, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, and dpp-4 inhibitors)
Beschreibung

Life Style Modification | Antidiabetics Oral | Sulfonylurea | Biguanides | Thiazolidinediones | alpha-Glucosidase Inhibitors | DPP-4 Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023676
UMLS CUI [1,2]
C3840684
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0038766
UMLS CUI [4]
C0005382
UMLS CUI [5]
C1257987
UMLS CUI [6]
C1299007
UMLS CUI [7]
C2917254
who read and signed the informed consent agreement
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic disease(s) requiring medication other than diabetes mellitus
Beschreibung

Chronic disease Requirement Pharmaceutical Preparations | Exception Diabetes Mellitus

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0013227
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0011849
type 1 diabetes mellitus or history of diabetic ketoacidosis
Beschreibung

Diabetes Mellitus, Insulin-Dependent | Diabetic Ketoacidosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011880
on insulin therapy or requiring insulin therapy
Beschreibung

Insulin regime | Requirement Insulin regime

Datentyp

boolean

Alias
UMLS CUI [1]
C0557978
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0557978
history of gastrointestinal surgery excluding appendectomy, hernia repair and hemorrhoid surgery
Beschreibung

Gastrointestinal Surgical Procedure | Exception Appendectomy | Exception Herniorrhaphy | Exception Hemorrhoid operation

Datentyp

boolean

Alias
UMLS CUI [1]
C0524722
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003611
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019328
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0176866
serum aspartate aminotransferase (ast) and/or alanine aminotransferase (alt) to be more than 2.5 times above the upper limit of normal
Beschreibung

Aspartate aminotransferase increased | Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
estimated glomerular filtration rate to be less than 50 ml/min/1.73m2
Beschreibung

Estimated Glomerular Filtration Rate

Datentyp

boolean

Alias
UMLS CUI [1]
C3811844
genetic disorders associated with digestion and absorption such as galactose intolerance, lapp lactase deficiency, and glucose-galactose malabsorption
Beschreibung

Hereditary Diseases Associated with Digestion | Hereditary Diseases Associated with Absorption | Galactosemias | Lapp Lactase deficiency | Glucose-galactose malabsorption

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019247
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0012238
UMLS CUI [2,1]
C0019247
UMLS CUI [2,2]
C0332281
UMLS CUI [2,3]
C0237442
UMLS CUI [3]
C0016952
UMLS CUI [4,1]
C0337904
UMLS CUI [4,2]
C0302813
UMLS CUI [5]
C0268186
history of hypersensitivity including anaphylaxis and angioedema to mosapride citrate, linagliptin, or paracetamol (acetaminophen)
Beschreibung

Hypersensitivity Mosapride citrate | Hypersensitivity Linagliptin | Allergy to acetaminophen | Anaphylaxis Mosapride citrate | Anaphylaxis Linagliptin | Anaphylaxis Acetaminophen | Angioedema Paracetamol Induced

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0245956
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2746078
UMLS CUI [3]
C0570513
UMLS CUI [4,1]
C0002792
UMLS CUI [4,2]
C0245956
UMLS CUI [5,1]
C0002792
UMLS CUI [5,2]
C2746078
UMLS CUI [6,1]
C0002792
UMLS CUI [6,2]
C0000970
UMLS CUI [7,1]
C0002994
UMLS CUI [7,2]
C0000970
UMLS CUI [7,3]
C0205263
history of asthma associated with aspirin or nonsteroidal anti-inflammatory drugs (nsaids)
Beschreibung

Asthma Associated with Aspirin | Asthma Associated with NSAIDs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0004057
UMLS CUI [2,1]
C0004096
UMLS CUI [2,2]
C0332281
UMLS CUI [2,3]
C0003211
currently taking drugs that can prolong qt interval, including procainamide, quinidine, flecainide, sotalol, tricyclic antidepressants
Beschreibung

Pharmaceutical Preparations Causing Prolonged QT interval | Procainamide | Quinidine | Flecainide | Sotalol | Tricyclic Antidepressive Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0151878
UMLS CUI [2]
C0033216
UMLS CUI [3]
C0034414
UMLS CUI [4]
C0016229
UMLS CUI [5]
C0037707
UMLS CUI [6]
C0003290
currently taking anticholinergics such as atropine sulfate, scopolamine butylbromide
Beschreibung

Anticholinergic Agents | Atropine Sulfate | scopolamine butylbromide

Datentyp

boolean

Alias
UMLS CUI [1]
C0242896
UMLS CUI [2]
C0596005
UMLS CUI [3]
C0006519
child-bearing or lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
women in reproductive age who disagree with contraception with proper method or urine pregnancy test during the study period
Beschreibung

Childbearing Potential Contraceptive methods Unwilling | Childbearing Potential Urine pregnancy test Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430056
UMLS CUI [2,3]
C0558080
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT02180334

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Body mass index
Item
bmi < 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Hemoglobin A1c measurement | Life Style Modification | Antidiabetics Oral
Item
hba1c 6.5~8.0% for whom is on lifestyle modification only, 6.0~8.0% for whom is taking oral antidiabetic drug(s).
boolean
C0474680 (UMLS CUI [1])
C0023676 (UMLS CUI [2,1])
C3840684 (UMLS CUI [2,2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
Life Style Modification | Antidiabetics Oral | Sulfonylurea | Biguanides | Thiazolidinediones | alpha-Glucosidase Inhibitors | DPP-4 Inhibitors
Item
on lifestyle modification or oral antidiabetic therapy (sulfonylurea, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, and dpp-4 inhibitors)
boolean
C0023676 (UMLS CUI [1,1])
C3840684 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0038766 (UMLS CUI [3])
C0005382 (UMLS CUI [4])
C1257987 (UMLS CUI [5])
C1299007 (UMLS CUI [6])
C2917254 (UMLS CUI [7])
Informed Consent
Item
who read and signed the informed consent agreement
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chronic disease Requirement Pharmaceutical Preparations | Exception Diabetes Mellitus
Item
chronic disease(s) requiring medication other than diabetes mellitus
boolean
C0008679 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
Diabetes Mellitus, Insulin-Dependent | Diabetic Ketoacidosis
Item
type 1 diabetes mellitus or history of diabetic ketoacidosis
boolean
C0011854 (UMLS CUI [1])
C0011880 (UMLS CUI [2])
Insulin regime | Requirement Insulin regime
Item
on insulin therapy or requiring insulin therapy
boolean
C0557978 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C0557978 (UMLS CUI [2,2])
Gastrointestinal Surgical Procedure | Exception Appendectomy | Exception Herniorrhaphy | Exception Hemorrhoid operation
Item
history of gastrointestinal surgery excluding appendectomy, hernia repair and hemorrhoid surgery
boolean
C0524722 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003611 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019328 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0176866 (UMLS CUI [4,2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
serum aspartate aminotransferase (ast) and/or alanine aminotransferase (alt) to be more than 2.5 times above the upper limit of normal
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Estimated Glomerular Filtration Rate
Item
estimated glomerular filtration rate to be less than 50 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Hereditary Diseases Associated with Digestion | Hereditary Diseases Associated with Absorption | Galactosemias | Lapp Lactase deficiency | Glucose-galactose malabsorption
Item
genetic disorders associated with digestion and absorption such as galactose intolerance, lapp lactase deficiency, and glucose-galactose malabsorption
boolean
C0019247 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0012238 (UMLS CUI [1,3])
C0019247 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0237442 (UMLS CUI [2,3])
C0016952 (UMLS CUI [3])
C0337904 (UMLS CUI [4,1])
C0302813 (UMLS CUI [4,2])
C0268186 (UMLS CUI [5])
Hypersensitivity Mosapride citrate | Hypersensitivity Linagliptin | Allergy to acetaminophen | Anaphylaxis Mosapride citrate | Anaphylaxis Linagliptin | Anaphylaxis Acetaminophen | Angioedema Paracetamol Induced
Item
history of hypersensitivity including anaphylaxis and angioedema to mosapride citrate, linagliptin, or paracetamol (acetaminophen)
boolean
C0020517 (UMLS CUI [1,1])
C0245956 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2746078 (UMLS CUI [2,2])
C0570513 (UMLS CUI [3])
C0002792 (UMLS CUI [4,1])
C0245956 (UMLS CUI [4,2])
C0002792 (UMLS CUI [5,1])
C2746078 (UMLS CUI [5,2])
C0002792 (UMLS CUI [6,1])
C0000970 (UMLS CUI [6,2])
C0002994 (UMLS CUI [7,1])
C0000970 (UMLS CUI [7,2])
C0205263 (UMLS CUI [7,3])
Asthma Associated with Aspirin | Asthma Associated with NSAIDs
Item
history of asthma associated with aspirin or nonsteroidal anti-inflammatory drugs (nsaids)
boolean
C0004096 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0004057 (UMLS CUI [1,3])
C0004096 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0003211 (UMLS CUI [2,3])
Pharmaceutical Preparations Causing Prolonged QT interval | Procainamide | Quinidine | Flecainide | Sotalol | Tricyclic Antidepressive Agents
Item
currently taking drugs that can prolong qt interval, including procainamide, quinidine, flecainide, sotalol, tricyclic antidepressants
boolean
C0013227 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,3])
C0033216 (UMLS CUI [2])
C0034414 (UMLS CUI [3])
C0016229 (UMLS CUI [4])
C0037707 (UMLS CUI [5])
C0003290 (UMLS CUI [6])
Anticholinergic Agents | Atropine Sulfate | scopolamine butylbromide
Item
currently taking anticholinergics such as atropine sulfate, scopolamine butylbromide
boolean
C0242896 (UMLS CUI [1])
C0596005 (UMLS CUI [2])
C0006519 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
child-bearing or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Unwilling | Childbearing Potential Urine pregnancy test Unwilling
Item
women in reproductive age who disagree with contraception with proper method or urine pregnancy test during the study period
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0430056 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video